Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline in the treatment of acute ischemic stroke
2005-004825-25Phase 3Completed
- Sponsor
- Ferrer
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Citicoline with Placebo (2 arms). Primary endpoint: Functional recovery at 12 weeks. Started Apr 2006; status: completed.
02
Drugs
citicoline
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2005-004825-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004825-25.